Triamcinolone Topical

Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product

Aerosol Solution, External, as acetonide:

Kenalog: 0.147 mg/g (63 g, 100 g)

Generic: 0.147 mg/g (63 g, 100 g)

Cream, External, as acetonide:

Triderm: 0.1% (28.4 g, 85.2 g) [contains propylene glycol]

Generic: 0.025% (15 g, 80 g, 453.6 g, 454 g); 0.1% (15 g, 30 g, 80 g, 453.6 g, 454 g); 0.5% (15 g)

Kit, External, as acetonide:

Dermasorb TA: 0.1% [contains cetyl alcohol, milk protein, propylene glycol]

Pediaderm TA: 0.1% [DSC] [contains cetyl alcohol, methylparaben, polysorbate 80, propylene glycol, propylparaben]

Lotion, External, as acetonide:

Generic: 0.025% (60 mL); 0.1% (60 mL)

Ointment, External, as acetonide:

Trianex: 0.05% (17 g [DSC], 85 g [DSC], 430 g)

Generic: 0.025% (15 g, 80 g, 454 g); 0.1% (15 g, 30 g, 80 g, 453.6 g, 454 g); 0.5% (15 g)

Paste, Mouth/Throat, as acetonide:

Oralone: 0.1% (5 g)

Generic: 0.1% (5 g)

Therapy Pack, External, as acetonide:

Dermazone: 0.1% (1 ea) [contains propylene glycol]

Dermatoses (corticosteroid-responsive): Topical: Note: Frequency of application based upon severity of condition

Cream, ointment: Apply thin film to affected areas 2 to 4 times daily

Lotion:

0.025%: Apply a thin film to affected area 3 to 4 times daily

0.1%: Apply a thin film to affected area 2 to 4 times daily

Aerosol solution: Apply to affected area 3 to 4 times daily

Oral inflammatory and ulcerative lesions: Oral paste: Press a small amount (about 1/4 inch) to the lesion at bedtime; a larger quantity may be required for coverage of some lesions. For severe lesions, may be used 2 or 3 times daily after meals.

Dermatoses (corticosteroid-responsive): Children and Adolescents: Topical: Note: Frequency based upon severity of condition: Cream, ointment, lotion, aerosol solution: Refer to adult dosing.

There are no dosage adjustments provided in the manufacturer's labeling.

• Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?)

• Patient may experience stinging. Have patient report immediately to prescriber signs of high blood sugar (confusion, fatigue, increased thirst, increased hunger, polyuria, flushing, fast breathing, or breath that smells like fruit), signs of skin changes (pimples, stretch marks, slow healing, or hair growth), signs of adrenal gland problems (severe nausea, vomiting, severe dizziness, passing out, muscle weakness, severe fatigue, mood changes, lack of appetite, or weight loss), signs of Cushing's disease (weight gain in upper back or abdomen; moon face; severe headache; or slow healing), severe mouth irritation, skin irritation, vision changes, burning, dry skin, edema, skin discoloration, or skin thinning (HCAHPS).

• Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions.

Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients.

Do not use this medication if you are allergic to triamcinolone.

To make sure you can safely use triamcinolone topical, tell your doctor if you have any of these other conditions:

• any skin infection, especially tuberculosis infection of the skin;

• chicken pox or herpes infection (including cold sores);

• diabetes; or

• a stomach ulcer.

FDA pregnancy category C. It is not known whether triamcinolone topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.

It is not known whether triamcinolone topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Do not use this medication on a child without a doctor's advice. Children are more sensitive to the effects of triamcinolone topical.

Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222, especially if anyone has accidentally swallowed this medicine. An overdose of triamcinolone topical applied to the skin is not expected to produce life-threatening symptoms.

Usual Adult Dose for Dermatitis:

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema:

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Psoriasis:

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Stomatitis:

Paste: Press a small dab (about 1/4 inch) to the lesion until a thin film develops.

Comments:
-The paste should be applied at bedtime to permit steroid contact with the lesion throughout the night.
-It may be necessary to apply the paste two or three times a day, depending on the severity of symptoms.
-If regeneration has not occurred in seven days, additional investigation is recommended.

Use: Temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma

Usual Pediatric Dose for Dermatitis:

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema:

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Psoriasis:

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Stomatitis:

Paste: Press a small dab (about 1/4 inch) to the lesion until a thin film develops.

Comments:
-The paste should be applied at bedtime to permit steroid contact with the lesion throughout the night.
-It may be necessary to apply the paste two or three times a day, depending on the severity of symptoms.
-If regeneration has not occurred in seven days, additional investigation is recommended.

Use: Temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma

It is not likely that other drugs you take orally or inject will have an effect on topically applied triamcinolone topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.